New York Blood Center:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:New York Blood Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9347
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
New York Blood Center (NYBC) is a non-profit healthcare organization that offers blood collection and distribution. The organization’s blood products comprise red blood cells, plasma products, platelets, frozen blood and washed products, whole blood and granulocytes. It offers medical services such as cellular therapy, clinical services, hemophilia services, laboratory services and transfusion medicine services. NYBC’s clinical services include apheresis services, lipoprotein apheresis, autologous platelet rich plasma and bone marrow concentrate, and cell salvage. The organization caters to hospitals and patients. It operates in New York, New Jersey, Hudson Valley, Long Island, Connecticut and Pennsylvania. NYBC is headquartered in New York, the US.

New York Blood Center – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
New York Blood Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
New York Blood Center, Medical Devices Deals, 2012 to YTD 2018 9
New York Blood Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
New York Blood Center, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Pluristem Therapeutics to Enter into Agreement with New York Blood Center 11
New York Blood Center Enters into Agreement with University of California 12
Community Blood Center Forms Joint Venture with New York Blood Center 13
Cerus Enters Into Co-Development Agreement With New York Blood Center 14
New York Blood Center – Key Competitors 15
New York Blood Center – Key Employees 16
New York Blood Center – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Corporate Communications 18
Jun 12, 2017: New York Blood Center Announces New Trustees 18
Government and Public Interest 19
Nov 05, 2018: Celdara Medical and New York Blood Center receive SBIR contract for autoimmune discovery research 19
Oct 16, 2017: New York Blood Center’s Dr. Mohandas Narla Awarded Program Project Grant by the National Institute of Diabetes and Digestive and Kidney Diseases 20
Jun 19, 2017: $3.6 Million NIH Grant Awarded to NYBC Scientist for Research on River Blindness Vaccine 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
New York Blood Center, Pharmaceuticals & Healthcare, Key Facts 2
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
New York Blood Center, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
New York Blood Center, Deals By Therapy Area, 2012 to YTD 2018 8
New York Blood Center, Medical Devices Deals, 2012 to YTD 2018 9
New York Blood Center, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Pluristem Therapeutics to Enter into Agreement with New York Blood Center 11
New York Blood Center Enters into Agreement with University of California 12
Community Blood Center Forms Joint Venture with New York Blood Center 13
Cerus Enters Into Co-Development Agreement With New York Blood Center 14
New York Blood Center, Key Competitors 15
New York Blood Center, Key Employees 16
New York Blood Center, Subsidiaries 17

List of Figures
New York Blood Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
New York Blood Center, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
New York Blood Center, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
New York Blood Center, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[New York Blood Center:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CHC Group Ltd:企業の戦略的SWOT分析
    CHC Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • GrowMax Resources Corp (GRO):石油・ガス:M&Aディール及び事業提携情報
    Summary GrowMax Resources Corp (GrowMax), formerly Americas Petrogas Inc is an oil and gas company that offers exploration and development of conventional and unconventional oil and gas properties in Argentina. The company explores and develops phosphate and potassium-rich brine resources in northwe …
  • Citigroup Inc:戦略・SWOT・企業財務分析
    Citigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Citigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • JEOL Ltd. (6951):企業の財務・戦略的SWOT分析
    JEOL Ltd. (6951) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MetLife Inc:戦略・SWOT・企業財務分析
    MetLife Inc - Strategy, SWOT and Corporate Finance Report Summary MetLife Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • CITIC Telecom International Holdings Ltd (1883):企業の財務・戦略的SWOT分析
    CITIC Telecom International Holdings Ltd (1883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • Lidco Group Plc (LID)-医療機器分野:企業M&A・提携分析
    Summary Lidco Group Plc (LiDCO) is a medical device company that supplies hemodynamic equipment. The company offers products including LiDCOrapidv, LiDCOplus, LiDCOview and LiDCOrapid. Its LiDCOplus comprise lithium dilution, pulseCO algorithm, user display and others. LiDCO offers products to monit …
  • La-Z-Boy Inc (LZB):企業の財務・戦略的SWOT分析
    La-Z-Boy Inc (LZB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Marel hf:企業の戦略・SWOT・財務分析
    Marel hf - Strategy, SWOT and Corporate Finance Report Summary Marel hf - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • B. Braun Melsungen AG:戦略・SWOT・企業財務分析
    B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report Summary B. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • The Ensign Group Inc (ENSG):企業の財務・戦略的SWOT分析
    The Ensign Group Inc (ENSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Callitas Therapeutics Inc (LILY):医療機器:M&Aディール及び事業提携情報
    Summary Callitas Therapeutics Inc (Callitas Therapeutics), formerly M Pharmaceutical Inc, is a drug discovery and development company that offers ground-breaking drug treatments and biomedical technologies. The company’s products include weight management products, infertility products and women’s h …
  • Perrigo Company plc:企業の戦略・SWOT・財務分析
    Perrigo Company plc - Strategy, SWOT and Corporate Finance Report Summary Perrigo Company plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Taisei Corporation:企業の戦略・SWOT・財務情報
    Taisei Corporation - Strategy, SWOT and Corporate Finance Report Summary Taisei Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Consolidated Edison Inc (ED):石油・ガス:M&Aディール及び事業提携情報
    Summary Consolidated Edison, Inc. (Con Edison) is an investor-owned energy company that offers wide range energy related products and services through its subsidiaries. It operates regulated electricity, gas and steam businesses, and competitive energy businesses. Con Edison’s competitive energy bus …
  • Perma-Fix Environmental Services, Inc. (PESI):企業の財務・戦略的SWOT分析
    Perma-Fix Environmental Services, Inc. (PESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Genting Singapore Plc:戦略・SWOT・企業財務分析
    Genting Singapore Plc - Strategy, SWOT and Corporate Finance Report Summary Genting Singapore Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Atara Biotherapeutics Inc (ATRA):製薬・医療:M&Aディール及び事業提携情報
    Summary Atara Biotherapeutics Inc (Atara) is a biopharmaceutical company that develops T-cell based immunotherapies for the treatment of cancers, other autoimmune diseases, and severe viral infections. The company is evaluating its lead candidate tabelecleucel, formerly ATA129, in Phase 3 for the tr …
  • Columbia Sportswear Company (COLM):企業の財務・戦略的SWOT分析
    Columbia Sportswear Company (COLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Epinex Diagnostics Inc:企業の製品パイプライン分析2018
    Summary Epinex Diagnostics Inc (Epinex Diagnostics) is a medical device company that develops rapid diagnostic tests. The company’s products include over-the-counter test device, Epinex G1A Test system, Epinex ACR Test system, Epinex SimplySure PT-INR Test system and point-of-care test device, among …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆